SMTL ID : 1tcx.1

HIV TRIPLE MUTANT PROTEASE COMPLEXED WITH INHIBITOR SB203386

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-dimer

Ligands

1 x IM1: (2R,4S,5S,1'S)-2-PHENYLMETHYL-4-HYDROXY-5-(TERT-BUTOXYCARBONYL)AMINO-6-PHENYL HEXANOYL-N-(1'-IMIDAZO-2-YL)-2'-METHYLPROPANAMIDE(Non-covalent)

IM1.1: 25 residues within 4Å: Chain A: L.23, D.25, G.27, A.28, D.29, I.32, V.47, G.48, G.49, P.81, I.82, I.84 Chain B: R.8, L.23, D.25, G.27, A.28, D.29, I.32, V.47, G.48, G.49, I.50, P.81, I.84 22 PLIP interactions: 10 interactions with chain B, 12 interactions with chain A Hydrophobic interactions: B:L.23, B:A.28, B:I.32, B:V.47, B:I.50, B:P.81, B:I.84, A:L.23, A:A.28, A:I.32, A:V.47, A:P.81, A:I.82, A:I.84 Hydrogen bonds: B:G.27, A:D.25, A:G.27, A:G.27, A:D.29 Water bridges: B:R.8, B:I.50, A:I.50

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hoog, S.S. et al., Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity. Biochemistry (1996)

Release Date

1996-12-07

Peptides

HIV PROTEASE: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

HIV PROTEASE